机构：[1]Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[3]Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院
This study was supported by a grant from the 1.3.5 project for
disciplines of excellence from West China Hospital of Sichuan University
(No. ZYGD18027).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区外科
最新[2023]版：
大类|3 区医学
小类|3 区外科
第一作者：
第一作者机构：[1]Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Dekai,Zhou Jianfeng,Fu Ping.Prognostic significance of miRNA-21, 25, 100, 223 expression in esophageal cancer: A meta-analysis[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.11.001.
APA：
Liu Dekai,Zhou Jianfeng&Fu Ping.(2023).Prognostic significance of miRNA-21, 25, 100, 223 expression in esophageal cancer: A meta-analysis.Asian journal of surgery,,
MLA：
Liu Dekai,et al."Prognostic significance of miRNA-21, 25, 100, 223 expression in esophageal cancer: A meta-analysis".Asian journal of surgery .(2023)
